You may also like
Drug-Induced Thrombocytopenia: A Systematic Review of Published Case Reports
Annals of Internal Medicine, 1 December 1998. 129:886-890. James N. George, MD; Gary E. Raskob, MSc; Shehla Rizvi Shah, MD; Mujahid A. […]
7 min read
Successful Antithrombin Administration in Andexanet Alfa-Associated Heparin Resistance
During routine CPB, high-dose unfractionated heparin (UFH) prevents consumptive coagulopathy and the formation of thrombi within the CPB circuit and the patient's circulation. Prior treatment with andexanet alfa can pose difficulties in achieving adequate anticoagulation during CPB with UFH. The administration of antithrombin, in combination with UFH, may overcome these difficulties.
1 min read
Peripheral Extracorporeal Membrane Oxygenation System as Salvage Treatment of Patients with Refractory Cardiogenic Shock: Preliminary Outcome Evaluation
The novel Permanent Life Support (PLS; Maquet, Jostra Medizintechnik AG, Hirrlingen, Germany) as peripheral veno-arterial extracorporeal membrane oxygenation (ECMO) support system has been investigated as treatment for patients with refractory cardiogenic shock (CS).
1 min read